BR112016006153A2 - composição contendo polietileno glicol - Google Patents
composição contendo polietileno glicolInfo
- Publication number
- BR112016006153A2 BR112016006153A2 BR112016006153A BR112016006153A BR112016006153A2 BR 112016006153 A2 BR112016006153 A2 BR 112016006153A2 BR 112016006153 A BR112016006153 A BR 112016006153A BR 112016006153 A BR112016006153 A BR 112016006153A BR 112016006153 A2 BR112016006153 A2 BR 112016006153A2
- Authority
- BR
- Brazil
- Prior art keywords
- polyethylene glycol
- composition containing
- containing polyethylene
- salt
- formula
- Prior art date
Links
- 239000002202 Polyethylene glycol Substances 0.000 title abstract 3
- 229920001223 polyethylene glycol Polymers 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013195329 | 2013-09-20 | ||
| PCT/JP2014/074698 WO2015041294A1 (ja) | 2013-09-20 | 2014-09-18 | ポリエチレングリコール含有組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016006153A2 true BR112016006153A2 (pt) | 2017-08-01 |
Family
ID=52688941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016006153A BR112016006153A2 (pt) | 2013-09-20 | 2014-09-18 | composição contendo polietileno glicol |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20160228420A1 (https=) |
| EP (1) | EP3047850A4 (https=) |
| JP (2) | JP5856264B2 (https=) |
| KR (1) | KR20160060656A (https=) |
| CN (1) | CN105555271A (https=) |
| AU (1) | AU2014322111A1 (https=) |
| BR (1) | BR112016006153A2 (https=) |
| CA (1) | CA2924628A1 (https=) |
| EA (1) | EA201690621A1 (https=) |
| HK (2) | HK1220632A1 (https=) |
| IL (1) | IL244648A0 (https=) |
| MX (1) | MX2016003566A (https=) |
| MY (1) | MY163236A (https=) |
| PH (1) | PH12016500461A1 (https=) |
| SG (1) | SG11201602020QA (https=) |
| TW (1) | TW201518291A (https=) |
| WO (1) | WO2015041294A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2979802C (en) | 2015-03-17 | 2023-06-27 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition comprising polypeptide |
| US11090296B2 (en) | 2015-03-18 | 2021-08-17 | Santen Pharmaceutical Co., Ltd. | Sustained-release pharmaceutical composition |
| JP2017008047A (ja) * | 2015-06-25 | 2017-01-12 | 参天製薬株式会社 | 注射剤 |
| CN107708738B (zh) * | 2015-07-01 | 2022-03-25 | 参天制药株式会社 | 含有柠檬酸酯的贮库制剂 |
| CN106902117A (zh) * | 2015-12-23 | 2017-06-30 | 瑞阳(苏州)生物科技有限公司 | 一种预防或治疗脉络膜新生血管形成的药物 |
| EP3515444A4 (en) * | 2016-09-26 | 2020-06-03 | Reyoung (Suzhou) Biology Science & Technology Co., Ltd | COMPOSITION FOR TREATING EYE DISEASES AND METHOD FOR USE AND PRODUCTION |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA833692B (en) * | 1982-05-28 | 1985-02-27 | Beecham Group Plc | Pharmaceutical formulations |
| JPS59101478A (ja) * | 1982-11-29 | 1984-06-12 | Sunstar Inc | リグスチライドを安定に配合した水系組成物 |
| JPH09110698A (ja) * | 1995-10-19 | 1997-04-28 | Taiho Yakuhin Kogyo Kk | 経口用医薬組成物の製造法 |
| BRPI0507757A (pt) * | 2004-02-17 | 2007-07-10 | Santen Pharmaceutical Co Ltd | composto, composição farmacêutica, e agente terapêutico para uma doença na qual a angiogênese ou a hipermeabilidade vascular está envolvida |
| JP4626353B2 (ja) * | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | 置換又は無置換アミノ基を導入した４−ピリジルアルキルチオ基を有する新規環式化合物 |
| CN1918127B (zh) * | 2004-02-17 | 2012-02-15 | 参天制药株式会社 | 具有引入了取代或无取代氨基的4-吡啶基烷硫基的环状化合物 |
| US20060153920A1 (en) * | 2004-09-24 | 2006-07-13 | Ketan Amin | Lyophilized pharmaceutical compositions |
| DK1848431T3 (en) * | 2005-02-09 | 2016-04-18 | Santen Pharmaceutical Co Ltd | LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS |
| EP1962803A1 (en) | 2005-12-23 | 2008-09-03 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| KR20100051811A (ko) | 2007-07-20 | 2010-05-18 | 알콘, 인코퍼레이티드 | 눈에 수용체 티로신 키나제 저해(ｒｔｋｉ) 화합물을 전달하기 위한 약제학적 제제 |
| CA2706448C (en) * | 2007-11-26 | 2016-08-16 | Merial Limited | Solvent systems for pour-on formulations for combating parasites |
| AU2010221438C1 (en) | 2009-03-03 | 2015-01-29 | Alcon Research, Ltd. | Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye |
| NZ597495A (en) * | 2009-07-17 | 2013-08-30 | Santen Pharmaceutical Co Ltd | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof |
| SMT201700043T1 (it) * | 2010-01-28 | 2017-03-08 | Eagle Pharmaceuticals Inc | Formulazioni di bendamustina |
-
2014
- 2014-09-18 KR KR1020167008149A patent/KR20160060656A/ko not_active Withdrawn
- 2014-09-18 JP JP2014190339A patent/JP5856264B2/ja not_active Expired - Fee Related
- 2014-09-18 MY MYPI2016000477A patent/MY163236A/en unknown
- 2014-09-18 CA CA2924628A patent/CA2924628A1/en not_active Abandoned
- 2014-09-18 AU AU2014322111A patent/AU2014322111A1/en not_active Abandoned
- 2014-09-18 HK HK16108793.4A patent/HK1220632A1/zh unknown
- 2014-09-18 EA EA201690621A patent/EA201690621A1/ru unknown
- 2014-09-18 SG SG11201602020QA patent/SG11201602020QA/en unknown
- 2014-09-18 MX MX2016003566A patent/MX2016003566A/es unknown
- 2014-09-18 HK HK16109575.6A patent/HK1221407A1/en unknown
- 2014-09-18 WO PCT/JP2014/074698 patent/WO2015041294A1/ja not_active Ceased
- 2014-09-18 US US15/023,207 patent/US20160228420A1/en not_active Abandoned
- 2014-09-18 CN CN201480051151.8A patent/CN105555271A/zh active Pending
- 2014-09-18 TW TW103132199A patent/TW201518291A/zh unknown
- 2014-09-18 EP EP14845745.0A patent/EP3047850A4/en active Pending
- 2014-09-18 BR BR112016006153A patent/BR112016006153A2/pt not_active IP Right Cessation
-
2015
- 2015-12-10 JP JP2015240775A patent/JP2016094442A/ja active Pending
-
2016
- 2016-03-09 PH PH12016500461A patent/PH12016500461A1/en unknown
- 2016-03-17 IL IL244648A patent/IL244648A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL244648A0 (en) | 2016-04-21 |
| JP2015083565A (ja) | 2015-04-30 |
| SG11201602020QA (en) | 2016-04-28 |
| EP3047850A1 (en) | 2016-07-27 |
| HK1220632A1 (zh) | 2017-05-12 |
| WO2015041294A1 (ja) | 2015-03-26 |
| TW201518291A (zh) | 2015-05-16 |
| EP3047850A4 (en) | 2017-05-10 |
| MY163236A (en) | 2017-08-30 |
| CN105555271A (zh) | 2016-05-04 |
| JP2016094442A (ja) | 2016-05-26 |
| MX2016003566A (es) | 2016-06-02 |
| CA2924628A1 (en) | 2015-03-26 |
| HK1221407A1 (en) | 2017-06-02 |
| JP5856264B2 (ja) | 2016-02-09 |
| AU2014322111A1 (en) | 2016-04-07 |
| US20160228420A1 (en) | 2016-08-11 |
| PH12016500461A1 (en) | 2016-05-16 |
| KR20160060656A (ko) | 2016-05-30 |
| EA201690621A1 (ru) | 2016-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016011755A2 (pt) | derivado de ureia ou sal farmacologicamente aceitável do mesmo | |
| CY1122718T1 (el) | Σκευασμα συνδυασμου δυο αντι-ιικων ενωσεων | |
| BR112015021983A8 (pt) | compostos heterocíclicos, composições e usos dos mesmos | |
| EA201690598A1 (ru) | Аминогетероарил бензамиды в качестве ингибиторов киназы | |
| CY1120529T1 (el) | Προφαρμακα φουμαρικων αλατων και η χρηση τους στην αγωγη ποικιλων νοσων | |
| BR112014017749A8 (pt) | Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo | |
| BR112018003026A2 (pt) | composições compreendendo um inibidor de pi3k e um inibidor de hdac | |
| MX2014000556A (es) | Compuesto heterociclico fusionado y su uso para el control de plagas. | |
| CU20190058A7 (es) | Composiciones de aminoácidos relacionadas con mejoras de la función hepática | |
| BR112015016930A2 (pt) | formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina | |
| CO7111287A2 (es) | Composiciones plaguicidas y procesos relacionados | |
| MX2013003365A (es) | Composicion farmaceutica. | |
| BR112015022047A8 (pt) | uso de uma composição compreendendo nanopartículas contendo um fármaco da família limo e uma albumina | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| FR26C1014I1 (fr) | Compositions pharmaceutiques contenant de l'insuline | |
| UA116467C2 (uk) | Модулятори p2x7 | |
| CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| BR112016006153A2 (pt) | composição contendo polietileno glicol | |
| BR112014025041B8 (pt) | Composição farmacêutica | |
| EA201600122A1 (ru) | Новые изоиндолиновые или изохинолиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| BR112015006270A2 (pt) | composição de controle de peste e uso da mesma | |
| AR095097A1 (es) | Compuestos de fenoxietoxi | |
| EA201692270A1 (ru) | Производные нафтиридиндиона | |
| BR112015006464A2 (pt) | composição farmacêutica compreendendo rebamipida | |
| AR090975A1 (es) | N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2-dihidroquinolina-3-carboxamida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2532 DE 16-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |